Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
34.45
-28.18
-81.80%
Share Warrants & Outstandings
Total Reserve
4.76
53.63
-48.87
-91.12%
Shareholder's Funds
11.04
88.08
-77.04
-87.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
1.94
0.32
16.49%
Secured Loans
0.80
1.94
-1.14
-58.76%
Unsecured Loans
1.45
0.00
1.45
0.00%
Deferred Tax Assets / Liabilities
-0.02
-0.38
0.36
94.74%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.21
-0.21
-100.00%
Total Non-Current Liabilities
2.39
1.77
0.62
35.03%
Current Liabilities
Trade Payables
5.97
3.50
2.47
70.57%
Other Current Liabilities
3.70
1.32
2.38
180.30%
Short Term Borrowings
5.00
0.00
5.00
0.00%
Short Term Provisions
0.00
0.01
-0.01
-100.00%
Total Current Liabilities
14.67
4.82
9.85
204.36%
Total Liabilities
28.10
94.67
-66.57
-70.32%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
17.18
-16.08
-93.60%
Less: Accumulated Depreciation
0.14
5.76
-5.62
-97.57%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
11.41
-10.45
-91.59%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.29
-0.29
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.49
-3.49
-100.00%
Long Term Loans & Advances
0.00
17.47
-17.47
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.96
32.67
-31.71
-97.06%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
23.99
-23.27
-97.00%
Sundry Debtors
24.55
16.22
8.33
51.36%
Cash and Bank
0.20
6.83
-6.63
-97.07%
Other Current Assets
0.14
2.02
-1.88
-93.07%
Short Term Loans and Advances
1.55
12.95
-11.40
-88.03%
Total Current Assets
27.15
62.00
-34.85
-56.21%
Net Current Assets (Including Current Investments)
12.47
57.18
-44.71
-78.19%
Total Current Assets Excluding Current Investments
27.15
62.00
-34.85
-56.21%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
94.67
-66.57
-70.32%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
1.94
5.32
274.23%
Book Value per share (adjusted)
17.60
5.11
12.49
244.42%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024






